Hexima Limited

HXL

Hexima Ltd. is a clinical stage, anti-infectives focused biotechnology company. The company is headquartered in Melbourne, Victoria. The company went IPO on 2020-12-01. The firm is exploring opportunities for transactions with third parties which could enable the potential value of the Company’s assets, including its intellectual property and other intangible assets, to be realized.

Hydrix Limited

HYD

Hydrix Ltd. engages in the development, design, and commercialization of technologies in the micro-electronic-mechanical systems (MEMS) sensor industry. The company is headquartered in Mulgrave, Victoria and currently employs 60 full-time employees. The company went IPO on 2001-05-11. The firm is engaged in the development of comprehensive products. Its segments include Hydrix Services, Hydrix Medical and Hydrix Ventures. Hydrix Services segment offers a comprehensive range of engineering, development and regulatory consulting services, including software, electronics, mechanical, industrial design and general product development services. Hydrix Medical distributes disruptive cardiovascular technologies that address unmet needs of patients and healthcare providers. Products include the Guardian real-time heart attack warning system from Avertix Medical, Implicity’s cloud-based artificial intelligence (AI)-driven remote cardiac patient monitoring and data management solution, and Echo IQ’s AI technology. Hydrix Services segment’s portfolio companies include Gyder Surgical Pty Ltd, Avertix Medical Inc., Memphasys Limited, and Cyban Pty Ltd.